betahistine dihydrochloride
PolandDrugs containing this active substance
-
The medicine is used to treat Meniere's disease (characterized by dizziness, nausea, vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Catalent Germany Schorndorf GmbH
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (with nausea and/or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Catalent Germany Schorndorf GmbH
-
The medicine is used in the treatment of Ménière's disease (manifesting as dizziness, tinnitus, and hearing problems) and in the treatment of symptomatic vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmacêutica, S.A.
-
The medicine is used to treat Ménière's disease (manifesting as dizziness, ringing or roaring in the ears, and hearing problems) and to treat symptomatic vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC: N07CA01
Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmacêutica, S.A.
-
The medicine is used in the treatment of Ménière's disease (manifesting as dizziness, ringing or roaring in the ears, and hearing problems) and in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmacêutica, S.A.
-
The medicine is used to treat the symptoms of Ménière's disease, such as dizziness (a spinning sensation), tinnitus, and hearing loss, which may be accompanied by nausea, headaches, or hearing disturbances.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24.0 mg ATC: N07CA01
Manufacturer: Bluefish Pharmaceuticals AB
-
The medicine is used to treat the symptoms of Ménière's disease, such as dizziness (a spinning sensation), tinnitus, and hearing loss. It may also help with nausea, hearing disturbances, or headaches accompanying these symptoms.
Form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC: N07CA01
Manufacturer: Bluefish Pharmaceuticals AB
-
The medicine is used to treat the symptoms of Ménière's disease, such as dizziness (a spinning sensation), tinnitus, and hearing loss, which may be accompanied by nausea, hearing disturbances, or headache.
Form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC: N07CA01
Manufacturer: Bluefish Pharmaceuticals AB
-
The medicine is used to treat the symptoms of Ménière's disease, such as dizziness (a spinning sensation), tinnitus, and hearing loss, which may be accompanied by nausea, hearing disturbances, or headache.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Bluefish Pharmaceuticals AB
-
This medicine is used to treat the symptoms of Ménière's disease, such as vestibular vertigo, nausea, vomiting, tinnitus (ringing or buzzing in the ears), and hearing loss or difficulty hearing.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Laboratori FUNDACIO DAU
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (of vestibular origin), nausea, vomiting, hearing loss or disturbances, and tinnitus.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Dr. Max Pharma s.r.o. Medis International a.s.
-
The medicine is used to treat symptoms of Ménière's disease, such as dizziness (accompanied by nausea and vomiting), progressive hearing loss, and tinnitus. It is also used for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Biofarm Sp. z o.o.
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It is also used for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Viatris Healthcare
-
It is used in the treatment of Ménière's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Limited
-
It is used in the treatment of Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Viatris Healthcare
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Limited
-
The medicine is used to treat Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Limited
-
It is used in the treatment of Meniere's disease, which is characterized by dizziness (accompanied by nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Healthcare, Lda.
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Neuraxpharm Spain S.L.U.
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It is also used for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Viatris Healthcare
-
It is used in the treatment of Meniere's disease, which is characterized by dizziness (with nausea and vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Limited
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Limited
-
The medicine is used to treat Meniere's disease (manifesting as dizziness with nausea and vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Limited
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (accompanied by nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Medical
-
It is used in the treatment of Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris GX BV
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Limited
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Limited
-
It is used in the treatment of Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Limited
-
It is used in the treatment of Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris GX
-
The medicine is used to treat Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Healthcare Lda.
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (accompanied by nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris GX
-
The medicine is used in Meniere's disease (manifesting as dizziness, nausea, vomiting, tinnitus, or hearing loss) and in dizziness caused by abnormal function of the part of the inner ear responsible for balance.
Form: tablets, dispersible in the oral cavity
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Delpharm L'Aigle
-
The medicine is used in Meniere's disease (manifesting, among other things, as dizziness, nausea, tinnitus, or hearing loss) and in dizziness caused by abnormal function of the part of the inner ear responsible for balance.
Form: tablets, dispersible in the oral cavity
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Healthcare, Lda.
-
It is used in Meniere's disease (manifesting, among other things, as dizziness, nausea, tinnitus, or hearing loss) and in dizziness caused by abnormal function of the part of the inner ear responsible for balance.
Form: tablets, dispersible in the oral cavity
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris Healthcare, Lda.
-
The medicinal product is used for the treatment of certain types of dizziness.
Form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC: N07CA01
Manufacturer: Mylan B.V.
-
The medicine is intended for the treatment of certain types of dizziness.
Form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC: N07CA01
Manufacturer: Viat游戏副本 Ltd
-
The medicine is used in the treatment of certain types of dizziness.
Form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC: N07CA01
Manufacturer: Viat游戏副本 Ltd
-
The medicine is used to treat Ménière's disease, which is characterized by dizziness, nausea or vomiting, tinnitus, and loss or impairment of hearing.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris GX
-
It is used in the treatment of Ménière's disease, which is characterized by dizziness, nausea, vomiting, tinnitus, and loss or impairment of hearing.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Viatris GX
-
It is used to treat the symptoms of Meniere's disease, such as dizziness, tinnitus, hearing loss, and nausea, as well as for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC: N07CA01
Manufacturer: Aflofarm Farmacia Polska Ltd. Catalent Germany Schorndorf GmbH Losan Pharma GmbH
-
The medicine is used to treat the symptoms of Meniere's disease, such as dizziness, tinnitus, hearing loss, and nausea. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Aflofarm Farmacia Polska Ltd. Catalent Germany Schorndorf GmbH Losan Pharma GmbH
-
It is used to treat the symptoms of Meniere's disease, such as dizziness, tinnitus, hearing loss, and nausea. It also helps in the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Aflofarm Farmacja Polska Sp. z o.o. Catalent Germany Schorndorf GmbH
-
The medicinal product is used in the treatment of Ménière's disease (characterized by dizziness with nausea and vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Catalent Germany Schorndorf GmbH
-
The medicine is used in the treatment of Ménière's disease (manifesting as dizziness with nausea and vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC: N07CA01
Manufacturer: Catalent Germany Schorndorf GmbH
-
It is used in the treatment of Ménière's disease (manifesting as dizziness, nausea, vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Catalent Germany Schorndorf GmbH
-
This medicine is used to treat dizziness (of vestibular or labyrinthine origin), tinnitus (ringing in the ears), and hearing loss in individuals with Ménière's disease. It works by improving blood flow in the inner ear.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Emona Biopharma prodaja in posrednistvo d.o.o. Terapia S.A.
-
The medicine is used to treat dizziness (of vestibular or labyrinthine origin), tinnitus (ringing in the ears), and hearing loss in people suffering from Ménière's disease.
Form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC: N07CA01
Manufacturer: Emona Biopharma prodaja in posrednistvo d.o.o. Terapia S.A.
-
The medicine is used to treat dizziness (of vestibular or labyrinthine origin), tinnitus (ringing in the ears), and hearing loss in people with Ménière's disease. It works by improving blood flow in the inner ear.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Emona Biopharma prodaja in posrednistvo d.o.o. Terapia S.A.
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (often with nausea and vomiting), tinnitus, and hearing loss.
Form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
Manufacturer: Henning Arzneimittel GmbH & Co. KG
-
It is used in the treatment of Ménière's disease (manifesting as dizziness, nausea, vomiting, tinnitus, and progressive hearing loss) and for the symptomatic treatment of vestibular vertigo.
Form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
Manufacturer: Catalent Germany Schorndorf GmbH, Losan Pharma GmbH